Aldeyra Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 251.82M | 240.18M | 227.92M | 211.85M | 195.35M | 185.49M | 174.76M | 161.92M | 151.45M | 147.80M | 144.81M | 133.67M | 121.68M | 110.96M | 98.90M | 89.08M | 81.38M | 74.93M | 69.27M | 57.01M | ||||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 235.09M | 221.24M | 206.28M | 193.95M | 189.64M | 166.92M | 153.20M | 150.78M | 151.47M | 149.94M | 143.62M | 113.55M | 100.38M | 86.04M | 78.70M | 85.44M | 79.44M | 74.50M | 72.46M | 37.89M | ||||||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -37.38 | -37.30 | -40.60 | -43.17 | -35.46 | -29.72 | -34.20 | -19.62 | -17.73 | -11.86 | -18.84 | -37.70 | -33.67 | -35.21 | -21.57 | -21.61 | -16.81 | -14.03 | -7.57 | -0.25M | ||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.06 | 0.07 | 0.07 | 0.10 | 0.14 | 0.09 | 0.09 | 0.13 | 0.19 | 0.20 | 0.21 | 0.12 | 0.13 | 0.14 | 0.16 | 0.35 | 0.39 | 0.42 | 0.46 | |||||||||||||||||||||||||||||||||||
| Times Interest Earned | -37.38 | -37.30 | -40.60 | -43.17 | -35.46 | -29.72 | -34.20 | -19.62 | -17.73 | -11.86 | -18.84 | -37.70 | -33.67 | -35.21 | -21.57 | -21.61 | -16.81 | -14.03 | -7.57 | -0.25M | ||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -32.25 | -14.75 | -15.44 | -13.08 | -21.49 | -31.59 | -37.39 | -54.90 | -48.29 | -43.72 | -24.04 | -11.67 | -21.24 | -18.83 | -34.77 | -23.55 | -40.85 | -48.23 | -29.53 | -23.57 | ||||||||||||||||||||||||||||||||||
| Price to BookP/B | 2.32 | 1.13 | 1.36 | 1.34 | 1.93 | 2.70 | 4.25 | 3.80 | 3.21 | 1.73 | 1.71 | 2.00 | 3.77 | 4.19 | 5.43 | 4.16 | 6.38 | 7.04 | 2.42 | 3.39 | ||||||||||||||||||||||||||||||||||
| Enterprise Value | 393.04M | 102.90M | 107.28M | 114.93M | 148.88M | 233.28M | 418.77M | 341.67M | 252.04M | 64.95M | 48.26M | 30.46M | 179.01M | 173.60M | 241.87M | 124.88M | 238.75M | 241.60M | 36.94M | 83.39M | ||||||||||||||||||||||||||||||||||
| EV to EBIT | -25.45 | -6.68 | -6.51 | -6.49 | -10.07 | -17.03 | -24.92 | -33.03 | -26.39 | -10.65 | -5.14 | -1.69 | -11.09 | -10.47 | -23.20 | -12.28 | -29.84 | -36.23 | -10.41 | -14.25 | ||||||||||||||||||||||||||||||||||
| EV to EBITDA | -25.45 | -6.68 | -6.51 | -6.49 | -10.07 | -17.03 | -24.92 | -33.03 | -26.39 | -10.65 | -5.14 | -1.69 | -11.09 | -10.47 | -23.20 | -12.28 | -29.84 | -36.23 | -10.41 | -14.25 | ||||||||||||||||||||||||||||||||||
| Market Capitalization | 509.41M | 232.32M | 259.15M | 232.62M | 312.71M | 407.58M | 583.80M | 493.34M | 395.37M | 207.78M | 194.29M | 196.66M | 320.97M | 297.64M | 345.26M | 229.97M | 314.05M | 311.64M | 101.94M | 128.48M | ||||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -60.40 | -20.07 | -20.11 | -11.66 | -24.87 | -36.29 | -61.82 | -36.93 | -49.27 | 415.19 | -19.48 | -14.87 | -40.25 | -24.73 | -27.69 | -26.88 | -44.73 | -58.81 | -19.95 | -28.00 | ||||||||||||||||||||||||||||||||||
| EV to FCF | -46.60 | -8.89 | -8.32 | -5.76 | -11.84 | -20.77 | -44.34 | -25.58 | -31.41 | 129.80 | -4.84 | -2.30 | -22.45 | -14.42 | -19.40 | -14.60 | -34.00 | -45.59 | -7.23 | -18.17 | ||||||||||||||||||||||||||||||||||
| EV to CFO | -46.60 | -8.89 | -8.33 | -5.76 | -11.84 | -20.77 | -44.34 | -25.58 | -31.41 | 129.80 | -4.84 | -2.30 | -22.45 | -14.42 | -19.40 | -14.60 | -34.00 | -45.59 | -7.23 | -18.17 | ||||||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -21.72% | -24.61% | -29.25% | -33.25% | -37.62% | -36.84% | -39.69% | -38.02% | -38.81% | -34.09% | -28.74% | -40.58% | -47.49% | -65.09% | -72.27% | -89.53% | -85.40% | -74.84% | -63.15% | -50.82% | ||||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -21.17% | -24.06% | -27.76% | -31.21% | -33.21% | -33.44% | -34.82% | -32.15% | -30.17% | -25.40% | -20.72% | -28.33% | -36.81% | -50.33% | -58.34% | -56.82% | -53.08% | -45.17% | -39.51% | -40.44% |